Health Technology Assessments (HTA)
The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.
Decision support for low and middle-income countries
Reports
Projects
- Disinvestment of medical technologies in Specialist Healthcare Services
- Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
- Intermittent pneumatic compression to prevent deep vein thrombosis (DVT) in immobile patients with acute stroke
- Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
- Minimally Invasive Glaucoma Surgery (MIGS) for individuals with open-angle glaucoma. A health technology assessment
